Related Experiment Video
Updated: Jun 5, 2026

12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Laparostomy closure in stage 4S neuroblastoma
David James Keene1, Joanne Minford, Ross J Craigie
1Department of Paediatric Surgery, Royal Manchester Children's Hospital, M13 9WL Manchester, UK. dkeene@doctors.org.uk
Journal of Pediatric Surgery
|January 18, 2011
Summary
Pediatric laparostomy closure for open abdomens is challenging. This study reports a novel approach using extracellular matrix mesh and vacuum therapy for successful fascial and skin closure in stage 4S neuroblastoma.
Area of Science:
- Pediatric Surgery
- Oncology
- Wound Management
Background:
- Laparostomy in children, or open abdomen management, presents significant challenges for definitive closure.
- Optimal techniques for pediatric abdominal wall reconstruction after laparostomy remain poorly defined.
- Stage 4S neuroblastoma often necessitates emergency decompressive laparostomy due to abdominal compromise.
Observation:
- Two pediatric cases with stage 4S neuroblastoma underwent emergency decompressive laparostomy.
- The study evaluated the efficacy of different closure techniques, noting their respective advantages and disadvantages.
- This report details the application of a combined extracellular matrix mesh and vacuum-assisted closure therapy.
Findings:
- The combined use of extracellular matrix mesh and vacuum therapy facilitated successful fascial and skin closure.
- This innovative approach addressed the complexities of abdominal wall closure in pediatric patients with open abdomens.
- The technique proved effective in managing the abdominal compartment in these challenging neuroblastoma cases.
Implications:
- This case series suggests a promising new strategy for pediatric laparostomy closure, particularly in oncological emergencies.
- The findings may guide future surgical practice for complex abdominal wall reconstruction in pediatric oncology.
- Further research is warranted to validate this combined approach in larger pediatric cohorts.